Atlas Trials

Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic

Clinical trial NCT04437719 · COMPLETED

Trial details

NCT number
NCT04437719
Sponsor
Fondation Hôpital Saint-Joseph
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
OncologyCOVID-19
Start date
2020-06-29
Primary completion
2021-06-28
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.